(redirected from Hepatitis C virus)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: disease
References in periodicals archive ?
The hepatitis C virus is a blood-borne virus and the most common modes of infection are through exposure to small quantities of blood which may happen through injection drug use, unsafe injection practices, unsafe health care, and the transfusion of unscreened blood and blood products, or sexual contact with an infected person.
Second generation hepatitis C virus assays: performance when testing African sera.
Chiron is a leader in the field of hepatitis C virus due to the company's discovery and successful cloning of the virus in 1987.
Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.
Chiron is also in litigation with other parties regarding its hepatitis C virus protease patents.
Infections from the hepatitis C virus (HCV) have reached pandemic proportions, affecting almost 200 million people worldwide.
Hepatitis C virus infection in different populations in Cameroon.
Antisense drugs targeting hepatitis C virus, West Nile virus, and the oncogene c-myc found in the CSF after systemic administration to humans
For the first time, researchers report that the human body produces antibodies against the hepatitis C virus.
Patients with both the hepatitis C virus and HIV can have an increased chance of having liver failure during PEGASYS treatment.
About 90 percent of such cases show no evidence of the viruses responsible for hepatitis A or B; most probably result from hepatitis C virus, first identified in 1988.
Currently, the best indicator of treatment success is a sustained viral response (SVR), defined by undetectable hepatitis C virus RNA in the blood six months after the end of treatment.